Indian pharma drug for mental health disorder gets USFDA nod

The approval by the US Food and Drug Administration (USFDA) is for the abbreviated new drug application (ANDA) for risperidone for extended-release injectable suspension, Indian pharma major Lupin said in a regulatory filing